SCHEMBL7908202

SCHEMBL7908202

C[CH]NC(=O)Nc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.64
▸ EPHX1 P07099 2/20 0.64
▸ TP53 P04637 1/20 0.64
▸ TSHR P16473 1/20 0.64
▸ EPHX2 P34913 1/20 0.64
▸ CDK9 P50750 1/20 0.64
▸ CLK4 Q9HAZ1 1/20 0.64
▸ NPC1 O15118 5/20 0.57
▸ RAB9A P51151 5/20 0.57
▸ KMT2A Q03164 4/20 0.57
▸ TAAR1 Q96RJ0 3/20 0.57
▸ CASP3 P42574 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55
▸ HSD17B10 Q99714 2/20 0.54
▸ NAPRT Q6XQN6 1/20 0.54
▸ MAOA P21397 2/20 0.53
▸ MAOB P27338 2/20 0.53
▸ MAPT P10636 1/20 0.53
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28774232 0.84 SMN1; SMN2 (0.59) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL27599974 0.81 SMN1; SMN2 (0.67) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL27981353 0.80 MAOA (0.58) SMN1; SMN2TSHRNPC1RAB9AKMT2A
Diphenylurea SCHEMBL133103 0.79 SMN1; SMN2 (1.00) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL20058336 0.79 SMN1; SMN2 (0.64) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL14855370 0.79 SMN1; SMN2 (0.64) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL8916099 0.79 SMN1; SMN2 (0.64) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL17151485 0.79 SMN1; SMN2 (0.64) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL7860790 0.79 SMN1; SMN2 (0.57) SMN1; SMN2EPHX1TP53TSHREPHX2
SCHEMBL4588029 0.78 KMT2A (0.71) SMN1; SMN2EPHX1TP53TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0438230-B1 Indole-substituted five-membered heteroaromatic compounds MERCK SHARP & DOHME (GB) 1997-04-23 — — EP claimed
US-6211219-B1 DRUGS, ANALGESICS AND AGONISTS MERCK SHARP & DOHME LTD. (GB) 2001-04-03 — — US disclosed
US-6127388-A Azetidine, pyrrolidine and piperidine derivatives as 5-HT1D receptor agonists MERCK SHARP & DOHME LTD. (GB) 2000-10-03 — — US disclosed
US-5998416-A Piperazine, piperidine and tetrahydropyridine derivatives as 5-HT receptor agonists MERCK SHARP & DOHME LTD. (GB) 1999-12-07 — — US disclosed
US-5902819-A Triazole derivatives MERCK SHARP & DOHME LTD. (GB) 1999-05-11 — — US disclosed
EP-0906308-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES AS 5-HT1D RECEPTOR AGONISTS MERCK SHARP & DOHME LTD. (GB) 1999-04-07 — — EP disclosed
US-5837715-A 3-fluoro-4-aminopiperidine derivatives as 5-HT receptor agonists MERCK SHARP & DOHME LTD. (GB) 1998-11-17 — — US disclosed
WO-1997045426-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES AS 5-HT1D RECEPTOR AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1997-12-04 — — WO disclosed
EP-0501568-B1 Substituted cyclic sulphamide derivatives MERCK SHARP & DOHME (GB) 1997-08-20 — — EP disclosed
EP-0778275-A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists MERCK SHARP & DOHME LTD. (GB) 1997-06-11 — — EP disclosed
WO-1993023396-A1 FUSED IMIDAZOLE AND TRIAZOLE DERIVATIVES AS 5-HT1 RECEPTOR AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1993-11-25 — — WO disclosed
WO-1993021182-A1 HETEROAROMATIC 5-HYDROXYTRYPTAMINE RECEPTOR AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1993-10-28 — — WO disclosed
WO-1993020066-A1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1993-10-14 — — WO disclosed
WO-1993018029-A1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1993-09-16 — — WO disclosed
US-5208248-A Hydroxytryptamine Receptor Agonists MERCK SHARPE & DOHME, LTD. (GB) 1993-05-04 — — US disclosed
US-5194440-A Treatment for migraine; selective agonist MERCK SHARP & DOHME LTD. (GB) 1993-03-16 — — US disclosed
EP-0501568-A1 Substituted cyclic sulphamide derivatives MERCK SHARP & DOHME LTD. (GB) 1992-09-02 — — EP disclosed
EP-0497512-A2 Imidazole, triazole and tetrazole derivatives MERCK SHARP & DOHME LTD. (GB) 1992-08-05 — — EP disclosed
EP-0494774-A1 Indazole-substituted fivemembered heteroaromatic compounds MERCK SHARP & DOHME LTD. (GB) 1992-07-15 — — EP disclosed
EP-0438230-A2 Indole-substituted five-membered heteroaromatic compounds MERCK SHARP & DOHME LTD. (GB) 1991-07-24 — — EP disclosed
Send feedback